Search

Displaying results 6911 - 6920 of 10000 in total
  1. Drug

    Tilozepine

    go.drugbank.com/drugs/DB19846
    Experimental

    Tilozepine is a small molecule drug. The usage of the INN stem '-zepine' in the name indicates that Tilozepine is a tricyclic compound. Tilozepine has a monoisotopic molecular weight of 331.09 Da.

  2. Drug

    Dinazafone

    go.drugbank.com/drugs/DB19871
    Experimental

    Dinazafone is a small molecule drug. The usage of the INN stem '-zafone' in the name indicates that Dinazafone is a alozafone derivative. Dinazafone has a monoisotopic molecular weight of 356.13 Da.

  3. Drug

    Darenzepine

    go.drugbank.com/drugs/DB19958
    Experimental

    Darenzepine is a small molecule drug. The usage of the INN stem '-zepine' in the name indicates that Darenzepine is a tricyclic compound. Darenzepine has a monoisotopic molecular weight of 347.16 Da.

  4. Drug

    Apadoline

    go.drugbank.com/drugs/DB20043
    Experimental

    Apadoline is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Apadoline is a analgesic. Apadoline has a monoisotopic molecular weight of 395.2 Da.

  5. Drug

    Edronocaine

    go.drugbank.com/drugs/DB20130
    Experimental

    Edronocaine is a small molecule drug. The usage of the INN stem '-caine' in the name indicates that Edronocaine is a local anaesthetic. Edronocaine has a monoisotopic molecular weight of 251.19 Da.

  6. Drug

    Ruzadolane

    go.drugbank.com/drugs/DB21444
    Experimental

    Ruzadolane is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Ruzadolane is a analgesic. Ruzadolane has a monoisotopic molecular weight of 375.13 Da.

  7. Drug

    J147

    go.drugbank.com/drugs/DB13957
    Experimental

    J147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. … [A31606,A31607,A31608] It is a curcumin derivative and a potent neurogenic and neuroprotective drug candidate initially developed for the treatment of neurodegenerative conditions associated with aging

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesSynonyms: N-(2,4-Dimethylphenyl)-2,2,2-trifluoro-N'-[(E)-(3-methoxyphenyl)methylene]acetohydrazide
  8. Drug

    Tasurgratinib

    go.drugbank.com/drugs/DB21222
    Investigational

    Tasurgratinib is a small molecule drug. The usage of the INN stem '-gratinib' in the name indicates that Tasurgratinib is a fibroblast growth factor receptor (FGFR) inhibitor. … Tasurgratinib is under investigation in clinical trial NCT04962867 (NCCH2006/MK010 Trial (FORTUNE Trial)). Tasurgratinib has a monoisotopic molecular weight of 587.27 Da.

    Synonyms: E 7090
  9. Drug

    SLV319

    go.drugbank.com/drugs/DB05077
    Experimental

    SLV319 belongs to a novel class of agents called CB1 antagonists, which work by blocking the cannabinoid type 1 (CB1) receptor.

  10. Drug

    Recombinant Human Thrombopoietin

    go.drugbank.com/drugs/DB16364
    Investigational

    [A225691, A225696] This drug is used in the treatment of thrombocytopenia. … Recombinant human thrombopoietin is a full-length glycosylated cytokine produced by Chinese hamster ovary cells and is used to promote the generation of megakaryocytes and platelets.